Enhancing Trauma Care: Connecticut's Protocol Now Includes Junctional Tourniquets
Discover why the AAJT-S is the FDA-Cleared Choice for Critical Situations
New Protocol Update in Connecticut
Connecticut's recent protocol update demonstrates its resolve to combat preventable deaths in trauma care, by integrating junctional tourniquets into its emergency protocols.
Selecting the AAJT-S: FDA-Cleared for Critical Care
• FDA cleared for pelvic and junctional bleeding.
• Proven effectiveness in emergencies, supported by research.
• Targeted hemorrhage control in the axilla, abdomen, and inguinal areas.
AAJT-S: Proven Advantage in
Emergency Care
• Rapid deployment, lightweight/compact, FDA-cleared.
• Pre-assembled, ready-to-use.
• Application areas: Axilla, Abdomen, Inguinal, Pelvic Fractures.
• Can be used for up to 2 hours for abdominal placement and 4 hours for junctional placement.
AAJT-S Highlighted on Fox 61 News CT
The inclusion of junctional tourniquets in Connecticut's protocols represents a significant leap in emergency medical care, particularly for the treatment of non-compressible hemorrhages, a leading cause of preventable death.
AAJT-S Applications
Multi-functional Hemorrhage Control
